Endovascular treatment of peripheral artery disease is challenging in patients with CLTI and complex lesions, and optimal treatment strategies are not established. This meta-analysis was conducted to investigate the safety and performance of a helical centerline stent in these indications.

In this study, the authors retrospectively compared the outcomes of heparin-bonded expanded polytetrafluoroethylene (HePTFE) and ASV in patients undergoing below-the-knee femoropopliteal bypass for CLI. 

In this video, Dr. Eric Secemsky discusses a recent analysis of Medicare beneficiaries undergoing endovascular treatment for CLTI in both high- and low-volume facilities. 

Watch as Dr. Barry Katzen, president and founding board member of the CLI Global Society, discusses the importance of membership in the Society.

In this video from AMP 2024, Dr van den Berg discusses the current state of critical limb ischemia in Europe.